Short cDNA fragments covering the entire coding region for apolipoprotein (apo) B have been cloned In the pING expression vector. A monoclonal antibody specific for the Ag(d) epltope on apo B has been used, together with the expressed apo B peptldes, to locate this epltope to a stretch of 26 amlno acids. Sequencing of this region from several genomlc DNAs of known Ag(a,/d) genotype showed a single T-to-C substitution at nucleotide 1981, creating an Alu I restriction site and resulting In a val to ala residue change In the corresponding peptlde (at position 591 In the mature protein). Southern blots, using the Alu I restriction endonuclease and a short probe for this region of the cDNA, showed perfect correspondence between the restriction fragment length polymorphism and the Ag(a,/d) Immunochemlcal polymorphism In all 17 persons examined. (Arteriosclerosis 8:429-435, July/August 1988)
In the present report a monoclonal antibody 16 was first used to locate Ag(d) to a stretch of 26 amino acid residues on the apo B peptide. Sequencing of the genomic DNA from four individuals was then employed to show that a single base change in this region distinguished individuals who were Ag(a,/ai) from those who were Ag(d/d). The base substitution, which occurs at nucleotide 1981, changes the GTT codon for Val 591, corresponding to the Ag(a,) epitope, to the GCT codon for Ala 591, corresponding to the Ag(d) epitope. The substitution creates an Alul restriction site changing AGTT to AGCT, a fortuitous occurrence that enables the substitution to be identified on Southern blots; perfect correspondence was then found between the Alul RFLP and the Ag(a,/d) genotype for all 17 persons examined.
Methods

DNA Sources
The sources of the short fragments of apo B cDNA that were cloned into the pING expression vector were four, long clones spanning the entire coding sequence of apo B: A6c, 17 ABF, SB9, and AB1. 18 The last three were kindly provided by James Scott, MRC Clinical Research Center, Harrow, UK. Human genomic DNA was isolated from white blood cells as previously described. 13 
Enzymes and Blochemlcals
From Bethesda Research Laboratories (Gaithersburg, MD) and Boehringer Mannheim Biochemicals (Indianapolis, IN) we obtained restriction endonucleases and other DNA modifying enzymes. From Calbiochem (La Jolla, CA) we obtained L-arabinose. From Amersham (Arlington Heights, IL) we obtained alpha-^P-dCTP and dATP.
Construction of Apo B Expression Library
The four, long cDNA clones were cut with various restriction enzymes as described. 19 The fragments were For the exact data on these fragments, refer to reference 28. separated on agarose gels, electroeluted, and llgated into the pING expression vectors. 20 The recombinant plasmids were Introduced into E. coli MC1061 by the calcium chloride procedure. 18 The selection of the proper reading frame was confirmed by direct DNA sequencing of the pING plasmids using the chain termination method of Sanger et al. 21 and Pfeffer and Mierendorf. 22
Expression of Apo B Fragments
To express the apo B fusion proteins, MC 1061 cells containing the appropriate recombinant pING plasmids were induced with L-arabinose as described. 20 The cells were then lysed osmotically, and the whole cell lystes were used directly in the enzyme-linked immunosorbent assay (ELISA) for antibody binding.
Specific Amplification and Sequencing of Human Genomlc DNA
The polymerase chain reaction was performed as described 23 to specifically amplify the region of interest in the genomic DNA. After the reaction was completed, 3% of the reaction mixture was analyzed on an agarose gel. Southern blotting and hybridization were performed to locate the specifically amplified DNA fragment, which was then cut out of the gel and cloned into the pING vector for sequencing and expression.
Southern Blots and Ag Phenotyplng
Southern blots and Ag phenotyping were performed as described. 1315 ^P-labeled cDNA probes were prepared by random priming. 24
Reduction, Alkylatlon, and Dellpldatlon of LDL
Human plasma LDL were prepared by sequential flotation ultracentrifugation 27 as the lipoprotein fraction with buoyant densities between 1.02 and 1.05 g/ml. The LDL were reduced by adding 20 /J of 1 M DTT and 100 Hi 1 M Tris (pH 8.0) to 2 ml of LDL (4.6 mg/ml protein) in 2 mM ethylenediaminetetraacetic acid (EDTA) and were incubated at room temperature for 10 minutes. The reduced LDL were then alkylated by the addition of 100 fii 1 M iodoacetamide and were incubated at room temperature for 30 minutes.
DelipidatJon of LDL was performed as described. 2 * 27
Results
Apo B Expression Library
The four, long cDNA clones used to produce the expression library completely cover the apo B coding sequence, which extends from nucteotides 128 to 13 816 on the mRNA 1718 These were cut Into shorter cDNA fragments by using restriction endonucteases. These shorter fragments were cloned into the appropriate pING expression vectors. The resulting expression library completely covers the coding sequence, 28 as shown in Figure 1 .
Reaction of Solubllized Apo B with Antl-Ag Antibodies
It seemed unlikely that most of the short fragments of apo B expressed as fusion peptJdes would exhibit the same three-dimensional conformation as the corresponding sequence of apo B on the LDL surface. Therefore, a preliminary experiment was performed to determine which among the Ag epitopes would survive lipid extraction and/or reduction and alkylation of the apo B.
Two solutions of human apo B, solubilized as a complex with serum albumin, were prepared by lipid extraction of either unreduced or reduced and alkylated LDL, as described in the Methods section. These solutions, which contained apo B at a concentration of 1 mg/ml similar to that found in human plasma, were then used in the hemagglutination assay to determine the Ag phenotype. Controls of the native and the reduced and alkylated, unextraded LDL were also examined. The results are presented in Table 1 .
In Table 1 It may be seen that the only epitope that survived all of these treatments was Ag(d). Interestingly, reduction and alkylation of the intact LDL did not affect any of the Ag epitopes (row 2), but reactivity was lost with removal of the lipid for all of the epitopes except Ag(d) (rows 3 and 4). Apo B, delipidated and then purified by SDS gel preparative electrophoresis, regained reactivity for over half of the epitopes, probably because tin this sample, which did not contain bovine serum albumin, the factors Agfa!, c, g, t, i) were only detectable after pre-absorptJon of the sample with (type O Rh -) red cells, since this sample gave nonspecific agglutination with red cells.
R and A = reduction and alkylation. some SDS remained bound and acted as a lipid to reform recognizable structural features (row 5). This was lost upon reduction and alkylation (row 6). The last row, row 7, was a repeat of the intact LDL except that bovine serum albumin (BSA) was not added to this sample, and as expected, it gave the same pattern of reactivity; however, pre-absorption of the sample with (type O Rh-) red cells was required to prevent nonspecific agglutination of the red cells. Evidently the BSA protects against the nonspecific agglutination, perhaps by absorbing a contaminant. From these results, it appeared likely that the antibody recognizing the Ag(d) epitope would also bind to the expressed apo B fragments containing the corresponding amino acid sequence. Therefore, a monodonai antibody recognizing Ag(d) 18 was used to screen the expressed peptides.
Screening of Expression Library with Monoclonal Antibody H11G3
Monoclonal antibody H11G3 recognizes the Ag(d) epitope and distinguishes between it and the antithetical Ag(a,) epitope; 16 that is, H11G3 appears to bind about 20 times more tightly to Ag(d) in a competitive ELISA. 16 Figure 2 shows that H11G3 bound strongly to Ag(d/d) LDL and weakly to Ag(a,/a,) LDL and bacteria] lysates containing the expression peptides, A7h and EL16, but not to EL17 In the ELISA assay. The monoclonal antibody also bound strongly to EL5 (not shown). A7h is completely included within EL5, and it covers nucleotides 1459 to 2028. EL16 covers nucleotides 1950 to 3146, while EL17 spans 1199 to 1949. Therefore, the Ag(d) epitope was tentatively located to the region between 1950 to 2028, which is 79 base pairs (bp) or 26 amino acids.
In this study, there was one apparent anomaly: monoclonal antibody H11G3 bound weakly to lysates expressing cDNA fragment EL16, which includes the suspected 79 bp. The origin of this particular weakly binding EL16 fragment was cDNA clone ABF, while that of the strongly binding EL5 was A6c. Subsequent sequencing, illustrated below, has shown that ABF is Ag(a,) while A6c is Ag(d). Subsequently, a second version of EL16 was prepared from clone A6c, and Figure 2 shows that monoclonal H11G3 binds strongly to lysates of bacteria expressing EL16A6C and weakly to those expressing EL16ABF.
Genomlc Sequencing of Agfa^aJ and Ag(dd) Individuals
The region of 79 nucleotides presumed to contain the sequence specifying the Ag epitope also includes an intron located toward one end. This intron has been sequenced; 12 it is located between nucleotides 1957 and 1958 In the mRNA numbering system, and includes 260 bp. This separates the 79 bp region, which spans from 1950 to 2028, into two parts in the genomlc DNA. The first part is from 1950 to 1957, only 8 bp long, while the second The intron sequence is not numbered. The prime candidate for the Ag^/d) polymorphic site was 1981, with either a cytidine In the codon GCT for alanlne or a thymkflne in the codon GTT for valine. The single-underiined sequence Is the forward primer sequence, and the double-underlined sequence is complementary to the backward primer.
part is from 1958 to 2028, which is 71 bp in length. Two synthetic 20-nucleotide primers were constructed complementary to regions on opposite strands flanking a stretch of 97 nucleotides containing these 71 bp, as shown in Figure 3 . Thus, 137 bp were amplified, with the 71 bp stretch near the middle.
In this study, the genomic DNA was isolated and amplified from two individuals who were homozygous for Ag(a!) and two who were homozygous for Ag(d). After the amplification reaction, small aliquots (3%) of each mixture were analyzed on an agarose gel and, as shown in Figure  4A , both a prominent band and a smear of larger and smaller material were visualized. The prominent band was slightly smaller than the expected 137 bp, and when a Southern analysis was performed, this band did not hybridize to the EL5 cDNA fragment used as a probe. However, a region just above the band did hybridize strongly as shown in Figure 48 ; therefore, the 137 bp region was cut out of the gel and ligated into the pING vector. After the transformation, ampicillin-resistant colonies were screened with ^P-labeled EL5 insert to identify the recombinant clones that contained the specifically amplified region. Approximately 1000 colonies for each allele were screened, and about 1% were detected as positive. Figure 5A shows the sequences of the genomic DNA fragments from one of the Ag(d) and one of the Ag(a,) samples; the single base at nucleotide 1981 was altered: it was found to be a C for the two Ag(d) individuals, and a T for the two Ag(a,) individuals, as indicated in Figure 3 .
Shown In Figure 5B are sequencing gels for the two different EL16A6C and EL16ABF cDNA fragments, which also show the same C-to-T substitution at nucleotide 1981.
Expression of Cloned Genomic DNA
Since the amplified genomic sequences had been cloned in the pING vector in the correct reading frame, they could be expressed as fusion proteins; synthesis was initiated by addition of L-arabinose, as described in the Methods section. These fusion proteins are expected to possess the alternate amino add sequences corresponding to the amplified genomic sequences from the Ag(aVd) and Ag(a 1 /a,) individuals. Cell lysates were applied to nitrocellulose and analyzed by the ELISA assay for the binding of monoclonal antibody H11G3. The results for one Ag(d) and one Ag(a,) individual are shown in Figure  2 : strong binding of the antibody is observed on the lysates containing the peptides corresponding to genomic sequences from the Ag(d) individual, weak binding, on those from the Ag(a,) individual.
Southern Analysis of Genomic DNA with Alu Restriction Endonuclease
Because of the T <-> C polymorphism at nucleotide 1981, the sequence for the human apo B gene between residues 1979 and 1982 is either AGTT or AGCT. Fortuitously, AGCT is the palindromic sequence recognized by the Alul restriction endonuclease; thus, a restriction fragment length polymorphism is associated with this site. Since Alul sites also exist 49 bp upstream of nucleotide 1981 (in intron 13) and 201 bp downstream of nucleotide 1981 (in exon 14) two restriction fragments of 49 bp and 201 bp will be formed upon digestion when the Alul site is present, and one fragment of 250 bp will be formed when the Alul site is absent. The two alleles distinguished by the absence or presence of this restriction site may be called A1 and A2, respectively. Therefore, it becomes possible to distinguish between the three human phenotypes by digestion of their genomic DNA with the Alul restriction endonuclease and Southern analysis.
Genomic DNA from 17 individuals who were previously Ag phenotyped was digested with the Alul restriction endonuclease, separated by gel electrophoresis, transferred to nylon membrane, and probed with ^P-labeled EL5 insert. As shown in Figure 6 , fragments having the predicted sizes of 250 or 201 nucleotides are detected, permitting the determination of a unique genotype for each individual. (The 49 bp fragment is too small to be effectively bound to the nylon membrane under these conditions of transfer.) In Table 2 , the Alul genotypes determined by Southern analysis are correlated with the Ag(a,/d) genotypes determined by the hemagglutination assay for these 17 individuals. An exact correlation is found; the Alul A1 allele appears identical to the Ag(a,) allele. The probability that random chance will give identical genotypes for two sets of unrelated markers for 17 individuals with the frequencies observed in Table 2 is less than 1 in a million. Therefore, from the Southern analysis, we conclude either that the two markers are in strong linkage disequilibrium or that they are identical.
Discussion
Strong evidence is presented that the nucleotide alteration responsible for the Ag(a,/d) polymorphism has been identified. First, monoclonal antibody H11G3, which distinguishes between individuals possessing or lacking the Ag(d) epitope, 16 was shown to bind to expression peptide A7h and EL16, but not to EL17. Although this is not a quantitative assay because bacterial lysates, rather than the purified fusion proteins, were used, the total lack of binding to EL17 shown in Figure 2 is striking; moreover, polyclonal and monoclonal antibodies against EL17 bind well in the same assay (data not shown), indicating that the cells are producing much immunochemically reactive fusion protein. These data strongly suggest that the epitope recognized by H11G3 is located within the 26 residues at the C-terminal end of A7h, which are shared with EL16 but not with EL17.
Second, genomic amplification of the DNA from four individuals, two of whom were Ag(a 1 /a,) and two, Ag(d/d), identified a single consistent nucleotide difference in this region ( Figure 5 ).
Third, H11G3 bound strongly to the bacterial lysates containing fusion protein expressed by the cloned genomic DNA from the Ag(d) individual and weakly to that from the Ag(aO individual (Figure 2) .
Fourth, two cDNA fragments, EL16, covering the same region, were obtained by restriction enzyme digests from two different large 5' cDNA clones, A6c and ABF. Monoclonal antibody, H11G3, bound strongly to bacterial lysates expressing the fusion protein produced by EL16A6c but weakly to that from EL16ABF (Figure 3 ). When the cDNAs were sequenced, the same consistent nucleotide substitution was found.
Fifth, RFLP analysis confirms the assignment of the Ag(a,/d) polymorphism to nucleotide 1981. It could be argued that although the previous data identify the location of the polymorphic site recognized by monoclonal antibody H11G3, it is conceivable that this epitope is located close to, but is different from, the site actually recognized by the human allotypic antibodies used to define the Ag(at/d) polymorphism. The RFLP analysis, however, is independent of monoclonal antibody H11G3. Perfect agreement was found between the Ag(a 1 /d) genotype, determined using human allo-antisera in the hemagglutlnation assay and RFLP analysis in all 17 individuals studied.
The nucleotide substitution at 1981 had been previously identified from a comparison of six previously published sequences of human apo B cDNAs. 12 The significance of the present study lies in the identification of this change as being responsible for the Ag(a,/d) polymorphic epitope and also for demonstrating that it may be detected by RFLP analysis. This RFLP demonstration is important because of the limited supply of the human allo-antisera currently used for Ag phenotype analysis.
The locations of most of the five Ag epitopes along the apo B polypeptide have not yet been established. RFLP analysis strongly implicates the EcoRI site at nucleotide 12 699 as being co-incident with, or very close to, the Ag(t/z) polymorphism. 1314 The present report locates the Ag(a,/d) site at nucleotide 1981. Thus, with only two of the Ag markers presumably located, the Ag polymorphisms span almost the entire length of the apo B cDNA.
The Ag immunogenetic markers have been used in genetic, ethnological, and forensic studies, 45811 and many apo B haplotypes have been identified and their frequen-cies determined in different populations. Some epidemiclogic studies show statistically significant associations between individual Ag markers and elevated cholesterol, apo B, and triglyceride levels, 781011 although such elevations are not found in all studies. 9 ' 28 It is to be expected that apo B haplotypes may be more closely linked to serum lipids and apo B than are the individual markers. 15 The Ag(a,/d) epitopic site is one of the five markers used to define the Ag haplotypes; therefore, its characterization and location on the apo B structural DNA and its identification with a restriction site provide information and means of analysis which may prove useful in future studies of the apo B polymorphisms.
